Funded Tech Companies
Alector
Alector, based in San Francisco, raised money through AbbVie Biotech Ventures, Amgen Ventures and GV.
Company Overview
Company Name
Alector
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
131 Oyster Point Blvd. 600
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Alector (Nasdaq: ALEC) is combining state-of-the-art antibody technology and recent discoveries in neuroimmunolgy and human genetics to develop novel therapeutics for Alzheimer's disease, other forms of dementia, and mechanistically related neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/6/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Tillman Gerngross
Chief Executive Officer
Arnon Rosenthal
Chief Financial Officer
Calvin Yu
Chief Medical Officer
Robert Paul
VP - Bus. Development
Robert King
VP - Bus. Development
Sabah Oney
VP - General Counsel
Stephanie Yonker
VP - Human Resources
Clare Hunt
VP - Manufacturing
Christian Simonsen
VP - Operations
Omer Siddiqui
VP - R & D
Hua Long
Company Investors
- AbbVie Biotech Ventures
- Amgen Ventures
- GV (Krishna Yeshwant)
- Lilly Asia Ventures
- OrbiMed (Carl Gordon)
- Deerfield Capital
- New Leaf Venture Partners
- Polaris Partners (Terry McGuire)
- Dementia Discovery Fund
- Section 32
- Foresite Capital
- MRL Ventures
- Mission Bay Capital
- Casdin Capital
- Euclidean Capital
- Perceptive Advisors
- Federated Kaufmann Funds
- Merck Capital Ventures (Josh Resnick)
- Topspin Partners
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs